Clinical Trials Browser

Phase NA × OTHER × Hemostatic Disorders × Clear all

NCT07384013 2026-02-03

Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs

Phase NA Recruiting

Agnosia, Hemostatic Disorders

NCT03826043 2025-09-30

THEO

Phase NA Completed

Neoplasms, Thrombosis, Hemostatic Disorders

NCT05634005 2025-03-06

Clinical Decision Support for Blood Transfusions to Improve Guideline Adherence

Phase NA Completed

Classical hematologyLymphoid

Afibrinogenemia, Anemia, Lymphoma, Follicular, Thrombocytopenia, Hemostatic Disorders

NCT03993977 2020-12-16

ROTEM-SUR

Phase NA Withdrawn

Neoplasms, Blood Loss, Surgical, Hemostatic Disorders